Research ArticleOther Arthritides
Economic Analysis of the Use of Anti-DFS70 Antibody Test in Patients with Undifferentiated Systemic Autoimmune Disease Symptoms
Luca Moroni, Gabriela Restovic, Ricard Cervera, Gerard Espinosa, Odette Viñas, Milagros García and Laura Sampietro-Colom
The Journal of Rheumatology August 2020, 47 (8) 1275-1284; DOI: https://doi.org/10.3899/jrheum.190533
Luca Moroni
From the Department of Autoimmune Diseases, the Department of Immunology, and the Assessment of Innovations and New Technologies Unit, Hospital Clínic, University of Barcelona, Barcelona; Fundació Clínic per la Recerca Biomèdica, Barcelona; Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain; the Unit of Immunology, Rheumatology, Allergy and Rare Diseases, San Raffaele Scientific Institute, Milan,
Italy.
Gabriela Restovic
Ricard Cervera
Gerard Espinosa
Odette Viñas
Milagros García

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
The Journal of Rheumatology
Vol. 47, Issue 8
1 Aug 2020
Economic Analysis of the Use of Anti-DFS70 Antibody Test in Patients with Undifferentiated Systemic Autoimmune Disease Symptoms
Luca Moroni, Gabriela Restovic, Ricard Cervera, Gerard Espinosa, Odette Viñas, Milagros García, Laura Sampietro-Colom
The Journal of Rheumatology Aug 2020, 47 (8) 1275-1284; DOI: 10.3899/jrheum.190533
Economic Analysis of the Use of Anti-DFS70 Antibody Test in Patients with Undifferentiated Systemic Autoimmune Disease Symptoms
Luca Moroni, Gabriela Restovic, Ricard Cervera, Gerard Espinosa, Odette Viñas, Milagros García, Laura Sampietro-Colom
The Journal of Rheumatology Aug 2020, 47 (8) 1275-1284; DOI: 10.3899/jrheum.190533